Application of glucocorticoids in treatment of COVID-19
10.3760/cma.j.issn.1674-2397.2021.01.004
- VernacularTitle:糖皮质激素在新型冠状病毒肺炎治疗中的应用
- Author:
Wanru GUO
;
Kaijin XU
- From:
Chinese Journal of Clinical Infectious Diseases
2021;14(1):21-23
- CountryChina
- Language:Chinese
-
Abstract:
The infection of 2019-nCoV can lead to overexpression of inflammatory factors, triggering cytokine storm and causing serious damage to the body. Glucocorticoids have anti-inflammatory properties and may be an effective treatment option. The use and dosage of glucocorticoids in coronavirus disease 2019 (COVID-19) remains controversial. This article reviews the theoretical basis, clinical evidence, debates and specific measures of glucocorticoids in the treatment of COVID-19, to provide reference for rational application of glucocorticoids in the future.
